Results

Total Results: 33 records

Showing results for "author year description".

21. CDS Connect - Maintenance and Update Final Report (Year 6) (pdf file)
    cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2022.pdf
    January 01, 2022 - For more information on Year 1, please see the final report from that year. … For more information on Year 2, please see the final report from that year. … Figure 3 depicts the various FHIR versions that may be available to an author when downloading an artifact … To author and edit CDS artifacts, users must agree to the terms and conditions. … This described how the CDS Connect capabilities allow community members to author and share CDS artifacts

22. CDS Connect Implementation Guide Draft (doc file)
    cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_USPSTF%20Statin%20Use%20for%20the%20Primary%20Prevention%20of%20CVD%20in%20Adults_Final.docx
    October 01, 2017 - Version 1.0 September 2017 Disclaimer The findings and conclusions in this document are those of the author … Introduction 1 Background 1 Audience, Purpose, and Scope of the IG 1 Implementing and Using the Artifact 2 Description … Implementing and Using the Artifact Description and Purpose of the Artifact This artifact helps providers … factors (i.e., dyslipidemia, diabetes, hypertension, or smoking); and 3) they have a calculated 10-year … Table 1: Artifact Manifest Filename Purpose Author(s) USPSTF_Statin_Use_for_Primary_Prevention_of_CVD_in_Adults_FHIRv102

23. Dec-2016-Cholesterol-Wg-Notes (doc file)
    cds.ahrq.gov/sites/default/files/workgroups/211/dec-2016-cholesterol-wg-notes.docx
    January 01, 2016 - Management Work Group (WG) kick-off meeting with a welcome to the Cholesterol Management WG members and a description … · The following artifacts were validated as beneficial CDS artifacts: · 2013 ACC/AHA 10-Year ASCVD … Calculator may not be as accurate as the 10-Year one … with clinical ASCVD · Individuals with primary elevations of LDL-C>= 190 mg/dL · Individuals 40-75 year … of age and have LDLD-C 70-189 mg/dL and an estimated 10-year ASCVD risk of >= 7.5%.

24. CDS Connect Pilot Final Report Factors to Consider in Managing Chronic Pain: A Pain Management Summary (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/476/CDSConnectPilotFinalReport508gel10012018.pdf
    September 01, 2018 - The findings and conclusions in this document are those of the author … The application included a description of the research effort, the proposed implementation and evaluation … as well as provided critical information to use when planning for the CDS Connect project’s third year … Alternate Text Rule Name Status Description Figures alternate text Passed Figures require alternate … child of L Lbl and LBody Passed Lbl and LBody must be children of LI Headings Rule Name Status Description

25. Warfarin-Antidepressants Mdia Implementation Guide (doc file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1146/Warfarin-Antidepressants%20MDIA%20Implementation%20Guide.docx
    August 29, 2020 - publication No. 002 August 29, 2020 Disclaimer The findings and conclusions in this document are those of the author … Audience, Purpose, and Scope of this Implementation Guide 1 Implementing and Using This Artifact 1 Description … Implementing and Using This Artifact Description and Purpose of the artifact This artifact aims to address … Measure 6 Version 1.0 September 2017 Artifact Manifest … Table 1: Artifact Manifest Filename Purpose Author

26. CAMH Long Doc Template (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/711/Anthrax%20Post%20Exposure%20Prophylaxis%20Implementation%20Guide%20v2.0%2020190607.pdf
    June 07, 2019 - Prophylaxis Implementation Guide i Version 2.0 June 7, 2019 Record of Changes Version Date Author … / Owner Description of Change 1.0 September 10, 2018 The Health FFRDC Team First draft submitted … Implementing and Using This Artifact 2.1 Description and Purpose of the Artifact This CDS artifact … for Clinicians Using the CDS Exposure to anthrax is rare in the United States (<1 case reported per year … Clinical Decision Support Artifact Manifest Filename Purpose Author(s) Anthrax_Post_Exposure_Prophylaxis_FHIRv102

27. CAMH_Template_Long_Instructions (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/711/Anthrax_Post_Exposure_Prophylaxis_CDS_Validation_Report.pdf
    October 17, 2018 - Support) Validation Report ii Version 1.0 October 17, 2018 Record of Changes Version Date Author … / Owner Description of Change 1.0 October 17, 2018 CAMH Team First draft submitted for sponsor review … Section 3 provides a description of the synthetic pilot plan, rationale, and methodology. … ], which are used to tell a module to wait until a certain condition is met, can only specify the year … event 2018 Delay into year of initial provider visit Uniform random distribution: 220-250 days

28. CDS Connect Pilot Report: Preventive Health CDS Interventions (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1061/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
    September 01, 2019 - Each year, the CDS Connect team develops one or more CDS artifacts; implements the CDS in a healthcare … Of note, the Statin Use for the Primary Prevention of CVD artifact logic requires a calculated 10-year … in 2018 (i.e., CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10- Year … The application included a description of the research effort, the proposed implementation and evaluation … “Diabetes” • Artifacts: Abnormal Glucose: Screening; Statin Use; Patient-Facing 10-Year ASCVD Risk

29. CDS Connect Pilot Report: Preventive Health CDS Interventions (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1056/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
    September 01, 2019 - Each year, the CDS Connect team develops one or more CDS artifacts; implements the CDS in a healthcare … Of note, the Statin Use for the Primary Prevention of CVD artifact logic requires a calculated 10-year … in 2018 (i.e., CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10- Year … The application included a description of the research effort, the proposed implementation and evaluation … “Diabetes” • Artifacts: Abnormal Glucose: Screening; Statin Use; Patient-Facing 10-Year ASCVD Risk

30. CDS Connect Pilot Report: Preventive Health CDS Interventions (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1066/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
    September 01, 2019 - Each year, the CDS Connect team develops one or more CDS artifacts; implements the CDS in a healthcare … Of note, the Statin Use for the Primary Prevention of CVD artifact logic requires a calculated 10-year … in 2018 (i.e., CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10- Year … The application included a description of the research effort, the proposed implementation and evaluation … “Diabetes” • Artifacts: Abnormal Glucose: Screening; Statin Use; Patient-Facing 10-Year ASCVD Risk

31. CDS Connect Pilot Report: Preventive Health CDS Interventions (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1071/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
    September 01, 2019 - Each year, the CDS Connect team develops one or more CDS artifacts; implements the CDS in a healthcare … Of note, the Statin Use for the Primary Prevention of CVD artifact logic requires a calculated 10-year … in 2018 (i.e., CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10- Year … The application included a description of the research effort, the proposed implementation and evaluation … “Diabetes” • Artifacts: Abnormal Glucose: Screening; Statin Use; Patient-Facing 10-Year ASCVD Risk

32. CDS Connect Pilot Report: Preventive Health CDS Interventions (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/71/CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
    September 01, 2019 - Each year, the CDS Connect team develops one or more CDS artifacts; implements the CDS in a healthcare … Of note, the Statin Use for the Primary Prevention of CVD artifact logic requires a calculated 10-year … in 2018 (i.e., CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10- Year … The application included a description of the research effort, the proposed implementation and evaluation … “Diabetes” • Artifacts: Abnormal Glucose: Screening; Statin Use; Patient-Facing 10-Year ASCVD Risk

33. CDS Connect Pilot Report: Preventive Health CDS Interventions (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1061/2019%20CDS%20Connect_Year%203%20Pilot%20Report_Final.pdf
    January 01, 2019 - Each year, the CDS Connect team develops one or more CDS artifacts; implements the CDS in a healthcare … Of note, the Statin Use for the Primary Prevention of CVD artifact logic requires a calculated 10-year … in 2018 (i.e., CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment Tool for Baseline 10- Year … The application included a description of the research effort, the proposed implementation and evaluation … “Diabetes” • Artifacts: Abnormal Glucose: Screening; Statin Use; Patient-Facing 10-Year ASCVD Risk